NGS data may have an impact on therapeutic strategies as well: for instance, one of six (17%) of the radiation-associated breast angiosarcomas in our cohort featured the amplification of the KDR gene encoding the amplification of the VEGFR2 tyrosine kinase receptor. The gene discussed is KDR; the disease is breast angiosarcoma.